Peer-reviewed study shows positive evidence for Ivermectin

American GreatnessA newly released study from Brazil of over 150 thousand subjects found that regular prophylactic use of ivermectin “was associated with significantly reduced COVID-19 infection, hospitalization, and mortality rates.”

The largest ivermectin study to date was conducted in Itajaí, Brazil, between July 2020 and December 2020. It recently passed rigorous peer-review and was published this week, Dr. Pierre Kory noted on Twitter.

So here's the thing. Ivermectin is safe for use in humans; not perfectly, no, but safe enough for over the counter use in many places outside the US. There is strong but not conclusive evidence that ivermectin provides significant benefits to COVID-19 patients, especially when given early. Much of the evidence is anecdotal, but much consists of a variety of studies usually done outside the US.

Many studies done inside the US on another popular potential treatment, hydroxychloroquin, were designed in ways that appeared to deliberately ignore the recommendations from earlier successful trials, particularly that of early treatment and use in combination with other drugs. Some were outright fraudulent. I rather wonder if some of the failed US studies of Ivermectin are similarly sabotaged.

Bottom line: it doesn't hurt and it may help. It's cheap and plentiful. Keep studying it -- but why not try it, too, at least with willing patients?

This entry was published Thu Jan 20 23:55:14 CST 2022 by TriggerFinger and last updated 2022-01-20 23:55:14.0. [Tweet]

comments powered by Disqus

Subscribe to Atom Feed

I am not a lawyer, and nothing on this site should be taken as legal advice.

This site is run on custom blog software and is being actively developed. Please be forgiving of errors.

This website is an Amazon affiliate and will receive financial compensation for products purchased from Amazon through links on this site.